US 8318666
Use of leptin to treat metabolic abnormalities associated with lipoatrophy
granted A61KA61K31/155A61K31/426
Quick answer
US patent 8318666 (Use of leptin to treat metabolic abnormalities associated with lipoatrophy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/155, A61K31/426, A61K38/2264, A61K45/06